Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:CBM

Cambrex (CBM) Stock Price, News & Analysis

Cambrex logo

About Cambrex Stock (NYSE:CBM)

Advanced Chart

Key Stats

Today's Range
$59.99
$59.99
50-Day Range
$59.99
$59.99
52-Week Range
$33.80
$60.29
Volume
N/A
Average Volume
218,726 shs
Market Capitalization
$2.02 billion
P/E Ratio
21.66
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CBM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cambrex and its competitors with MarketBeat's FREE daily newsletter.

CBM Stock News Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
China CBM Group Co Ltd 08270
See More Headlines

CBM Stock Analysis - Frequently Asked Questions

Cambrex Co. (NYSE:CBM) issued its quarterly earnings data on Thursday, August, 2nd. The biotechnology company reported $0.74 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.69 by $0.05. The business's revenue was up 13.0% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cambrex investors own include Bristol Myers Squibb (BMY), Illumina (ILMN), AbbVie (ABBV), Meta Platforms (META), CVS Health (CVS), Gilead Sciences (GILD) and NVIDIA (NVDA).

Company Calendar

Last Earnings
8/02/2018
Today
7/13/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NYSE:CBM
CIK
820081
Fax
N/A
Employees
1,732
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$2.77
Trailing P/E Ratio
21.66
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$92.41 million
Net Margins
5.96%
Pretax Margin
N/A
Return on Equity
5.38%
Return on Assets
2.50%

Debt

Debt-to-Equity Ratio
0.76
Current Ratio
2.37
Quick Ratio
1.70

Sales & Book Value

Annual Sales
$532.09 million
Price / Sales
3.80
Cash Flow
$3.91 per share
Price / Cash Flow
15.36
Book Value
$19.48 per share
Price / Book
3.08

Miscellaneous

Outstanding Shares
33,720,000
Free Float
N/A
Market Cap
$2.02 billion
Optionable
Optionable
Beta
2.14
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NYSE:CBM) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners